CERUS CORP
public$CERS View Live Feed →
Total Raised
--
Contracts
$250,545,671
Patents
--
PAC Giving
--
Government Contracts & Awards
CERUS CORPORATION: LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE
$65,358,564Award Office of Assistant Secretary for Preparedness and Response Sep 20, 2024
CERUS CORPORATION: CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::I
$185,187,107Award Office of Assistant Secretary for Preparedness and Response Jun 17, 2016
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $CERS
No disclosed congressional trades found in $CERS.
Insider Trades (Form 4)
SELLChief Financial Officer
Green Kevin Dennis
$99,10597,276 shares Jul 2, 2026
SELLDirector
BJERKHOLT ERIC
$53,18020,454 shares Jun 12, 2026
Key People
Green Kevin Dennis
Chief Financial Officer
Insider
BJERKHOLT ERIC
Director
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro